BIND Therapeutics, Inc. (BIND) was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock is now trading above volatile price range of $7.71 to $8.76 in the past one month.
The company has seen no estimate revisions over the past 30 days, and the Zacks Consensus Estimate is unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
BIND Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked biotechnology stocks include AMAG Pharmaceuticals, Inc. (AMAG), Biogen Idec Inc. (BIIB) and Dyax Corp. (DYAX). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment